Its activation is a result of genetic lesions in PI3K genes and downstream effectors of the cascade such as AKT and mTOR. In particular, PIK3CA (PI3K-alpha) is a commonly mutated oncogene in T-ALL [11]. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.